Portfolio Update

RNS Number : 9789M
Intl. Biotechnology Trust PLC
26 January 2021
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

Portfolio Update

 

The Board of International Biotechnology Trust plc (the Company) announces the following unquoted portfolio event.

 

SV Fund VI's latest estimation values the Company's investment at $37.7m (£27.5m), an uplift of $6.2m (£4.5m) on the preceding valuation of $31.5m (£23.0m) which was included in the Company's Net Asset Value (NAV) calculation for 25 January 2021.

 

In line with the Company's accounting policy, valuation movements are reflected in the next reported NAV.  Therefore, the increase in NAV to be reported today, as at 26 January 2021, will be £4.5m or 11.2 pence per share.

 

 

Enquiries:

 

Telephone: 020 7421 7070

Email: IBT-IR@svhealthinvestors.com

SV Health Managers LLP

Fund Manager

 

27 January 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBIGDBLUDDGBL
Investor Meets Company
UK 100